nach oben

Erschienen in:

01.07.2023 | News item

Removing unused opioid analgesics from homes

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

The US FDA's Center for Drug Evaluation and Research (CDER) is introducing measures to remove unused opioid analgesics from homes, reports Dr Marta Sokolowska, CDER Deputy Center Director for Substance Use and Behavioral Health. Based on Centers for Disease Control and Prevention (CDC) data, there were approximately 110 000 overdose deaths in the US in 2022, most of which involved opioids, she says. …

From Our Perspective: CDER's Efforts to Expand Opioid Disposal Options Internet Document : 26 Jun 2023. Available from: URL: https://www.fda.gov/drugs/news-events-human-drugs/our-perspective-cders-efforts-expand-opioid-disposal-options

Titel: Removing unused opioid analgesics from homes
Publikationsdatum: 01.07.2023
Verlag: Springer International Publishing
Erschienen in: Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-023-42062-x

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Removing unused opioid analgesics from homes

Excerpt

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2023

Dexamethasone/mefenamic-acid

Multiple drugs

Multiple drugs

Desmopressin

Atezolizumab

Azathioprine/infliximab/methylprednisolone